Tesamorelin: Research into Visceral Fat Metabolism

Research Background

Tesamorelin is a GHRH analog. Laboratory research focuses on its role in reducing visceral fat and improving metabolic syndrome.

By stimulating growth hormone secretion, it promotes lipolysis, particularly the metabolism of visceral fat.

Cell model studies of visceral fat metabolism

Exploration of mechanisms underlying metabolic syndrome and cardiovascular risk

Laboratory validation of long-acting GHRH analogs

This content is for research and educational purposes only. Not for human consumption. No medical or therapeutic claims are made or implied.